Levodopa/Carbidopa/Entacapone Orion

Levodopa/Carbidopa/Entacapone, the active ingredient in Levodopa/Carbidopa/Entacapone Orion, is an antiparkinson agent presented as an oral tablet for oral use. It treats Parkinson's disease and motor fluctuations in adult patients. GNH USA supplies Levodopa/Carbidopa/Entacapone Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa/Entacapone is used in the management of Parkinsonian disorders and related motor complications. - Parkinson's disease: improves overall motor function and reduces rigidity and bradykinesia. - Parkinson's disease with motor fluctuations: decreases OFF periods and prolongs ON time. - Early‑stage Parkinson's disease: enhances central dopamine availability to support symptom control.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: transient light‑headedness, especially on standing. - Orthostatic hypotension: drop in blood pressure upon standing. - Dyskinesia: involuntary movements with prolonged use. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening hyperthermia and rigidity. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Hallucinations or psychosis: visual or auditory disturbances. - Cardiac arrhythmias: irregular heart rhythm. - Severe hypotension: marked drop in blood pressure requiring medical attention.

When prescribing Levodopa/Carbidopa/Entacapone, clinicians should consider several safety measures. - Cardiovascular monitoring: assess blood pressure and heart rate regularly. - Psychiatric evaluation: watch for hallucinations, confusion, or mood changes. - Renal and hepatic function: adjust use if severe impairment is present. - Concomitant MAO‑B inhibitors: avoid or separate dosing by at least 14 days. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Storage: Store below 25°C: keep in the original container, protect from moisture and light.

Levodopa/Carbidopa/Entacapone interacts with several drug classes that may alter its efficacy or safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): may diminish dopaminergic response. - High‑dose pyridoxine (vitamin B6): accelerates peripheral levodopa metabolism.

Moderate Interactions (Monitor Closely): - Antihypertensives: may potentiate orthostatic hypotension. - Iron or antacids: can reduce levodopa absorption; separate administration by at least 2 hours. - SSRIs or SNRIs: monitor for serotonin syndrome when combined with MAO‑B inhibitors.